Ready to play
Ready to play
An upcoming FDA panel is expected to recommend the legal production of up to seven peptides, prompting preparations from compounding pharmacies and telehealth companies to capitalize on the potential market. Currently, these peptides are only legal for research, but a large gray market exists, valued at approximately $3 billion, due to demand from wellness advocates and influencers. If approved, these peptides could become widely available, opening a multi-billion-dollar industry despite concerns about their safety, efficacy, and lack of FDA approval.
Notice: This Is an AI-Generated Summary
Comments (0)